Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

Biotechnology • Healthcare • Irving, TX, United States • CAI (NMS)

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

866 771 8946 750 West John Carpenter Freeway, Irving, TX 75039, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Caris Life Sciences: Stronger Fundamentals, Same Conclusion (CAI) - Seeking Alpha
Seeking Alpha • Dec 24
Caris Life Sciences (CAI): Rethinking Valuation After a Recent Share Price Rebound - Yahoo Finance
Yahoo Finance • Dec 17
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - PR Newswire
PR Newswire • Nov 5
Power Luke Thomas sells Caris Life Sciences (CAI) stock for $1.65m - Investing.com
Investing.com • Dec 12
Latham & Watkins Advises Caris Life Sciences on IPO - Latham & Watkins LLP
Latham & Watkins LLP • Jun 18

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Caris Life Sciences, Inc. had layoffs?
No layoff events have been recorded for Caris Life Sciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Caris Life Sciences, Inc. have?
Caris Life Sciences, Inc. has approximately 1,769 employees.
What industry is Caris Life Sciences, Inc. in?
Caris Life Sciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Caris Life Sciences, Inc. a publicly traded company?
Yes, Caris Life Sciences, Inc. is publicly traded under the ticker symbol CAI on the NMS. The company has a market capitalization of approximately $7.89 billion.
Where is Caris Life Sciences, Inc. headquartered?
Caris Life Sciences, Inc. is headquartered in Irving, TX, United States at 750 West John Carpenter Freeway, Irving, TX 75039, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.